Search Within

Natasha Rekhtman

  1. "Brian Houck-Loomis"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (4)
Groups
  1. Department of Medicine (9)
  2. Department of Pathology and Laboratory Medicine (9)
  3. GSK Faculty (9)
  4. Sloan Kettering Institute Postdocs (9)
  5. Solid Tumor Oncology Division (9)
  6. Thoracic Oncology (9)

More Groups

People
  1. Brian Houck-Loomis (9)
  2. Alvaro Quintanal Villalonga (8)
  3. Charles Rudin (8)
  4. Helena Yu (7)
  5. Hirokazu Taniguchi (7)
  6. Jacklynn Egger (7)

More People

Years
  1. 2024 (1)
  2. 2022 (3)
  3. 2021 (5)
Publications
  1. Journal of Clinical Oncology (2)
  2. Journal of Thoracic Oncology (2)
  3. Annals of Oncology (1)
  4. Cancer Discovery (1)
  5. Cancer Research (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. American Society of Clinical Oncology (2)
  3. Elsevier Inc. (2)
  4. Biomed Central Ltd (1)
  5. Oxford University Press (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intratumoral escherichia is associated with improved survival to single-agent immune checkpoint inhibition in patients with advanced non–small-cell lung cancer
    Journal Article

    Elkrief, A.; Montesion, M.; Sivakumar, S.; Hale, C.; Bowman, A. S.; Begüm Bektaş, A.; Bradic, M.; Kang, W.; Chan, E.; Gogia, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • AKT pathway as a therapeutic target to constrain lineage plasticity leading to histological transdifferentiation
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; Bhanot, U. K.; Egger, J.; Qiu, J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • AKT inhibition as a therapeutic strategy to constrain histological transdifferentiation in EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Egger, J. V.; Bhanot, U.; Qiu, J.; De Stanchina, E.; Rekhtman, N.; Houck-Loomis, B.; Koche, R. P.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • AKT inhibition as a therapeutic strategy to constrain histological transdifferentiation in EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Rekhtman, N.; Houck-Loomis, B.; Koche, R. P.; Yu, H. A.; Sen, T.; Rudin, C. M.
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Multiomic analysis of lung tumors defines pathways activated in neuroendocrine transformation
    Journal Article

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Hasan, M. M.; Chavan, S. S.; Meng, F.; Uddin, F.; Manoj, P.; Donoghue, M. T. A.; Won, H. H.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Multi-omic characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y.; Hasan, M.; Chavan, S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; Chan, J.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Multi-omic characterization of lung tumors identify AKT and EZH2 as potential therapeutic targets in adenocarcinoma-to-squamous transdifferentiation
    Meeting Abstract

    Quintanal-Villalonga, Á.; Taniguchi, H.; Zhan, Y. A.; Hasan, M. M.; Chavan, S. S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; Ciampricotti, M.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
    Journal Article

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Hasan, M. M.; Chavan, S. S.; Meng, F.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; more...
    Journal of Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • Comprehensive molecular and clinicopathologic analysis of 200 pulmonary invasive mucinous adenocarcinomas identifies distinct characteristics of molecular subtypes
    Journal Article

    Chang, J. C.; Offin, M.; Falcon, C.; Brown, D.; Houck-Loomis, B. R.; Meng, F.; Rudneva, V. A.; Won, H. H.; Amir, S.; Montecalvo, J.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save